View Item 

Show simple item record

Clinicopathological findings in female‐to‐male gender‐affirming breast surgery
dc.contributor.authorEast, Ellen G
dc.contributor.authorGast, Katherine M
dc.contributor.authorKuzon, William M
dc.contributor.authorRoberts, Emily
dc.contributor.authorZhao, Lili
dc.contributor.authorJorns, Julie M
dc.date.accessioned2017-12-15T16:47:50Z
dc.date.available2019-02-01T19:56:25Zen
dc.date.issued2017-12
dc.identifier.citationEast, Ellen G; Gast, Katherine M; Kuzon, William M; Roberts, Emily; Zhao, Lili; Jorns, Julie M (2017). "Clinicopathological findings in female‐to‐male gender‐affirming breast surgery." Histopathology 71(6): 859-865.
dc.identifier.issn0309-0167
dc.identifier.issn1365-2559
dc.identifier.urihttps://hdl.handle.net/2027.42/139962
dc.publisherAmerican Psychiatric Association
dc.publisherWiley Periodicals, Inc.
dc.subject.othertransgender
dc.subject.otherbreast
dc.subject.othergender dysphoria
dc.subject.otherpathology
dc.titleClinicopathological findings in female‐to‐male gender‐affirming breast surgery
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/139962/1/his13299.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/139962/2/his13299_am.pdf
dc.identifier.doi10.1111/his.13299
dc.identifier.sourceHistopathology
dc.identifier.citedreferenceSlagter MH, Gooren LJG, Scorilas A, Petraki CD, Diamandis EP. Effects of long‐term androgen administration on breast tissue of female‐to‐male transsexuals. J. Histochem. Cytochem. 2006; 54; 905 – 910.
dc.identifier.citedreferenceGrynberg M, Fanchin R, Dubost G et al. Histology of genital tract and breast tissue after long‐term testosterone administration in a female‐to‐male transsexual population. Reprod. Biomed. Online 2010; 20; 553 – 558.
dc.identifier.citedreferenceGoehring C, Morabia A. Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol. Rev. 1997; 19; 310 – 327.
dc.identifier.citedreferenceDavis HH, Simons M, Davis JB. Cystic disease of the breast: relationship to carcinoma. Cancer 1964; 17; 957 – 978.
dc.identifier.citedreferenceKuroda H, Ohnisi K, Sakamoto G, Itoyama S. Clinicopathological study of breast tissue in female‐to‐male transsexuals. Surg. Today 2008; 38; 1067 – 1071.
dc.identifier.citedreferenceRohan TE, Negassa A, Chlebowski RT et al. Estrogen plus progestin and risk of benign proliferative breast disease. Cancer Epidemiol. Biomarkers Prev. 2008; 17; 2337 – 2343.
dc.identifier.citedreferenceMcDivitt RW, Stevens JA, Lee NC, Wingo PA, Rubin GL, Gersell D. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group. Cancer 1992; 69; 1408 – 1414.
dc.identifier.citedreferenceLondon SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992; 267; 941 – 944.
dc.identifier.citedreferenceSanten RJ. Benign breast disease in women. In De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A eds. Endotext. South Dartmouth, MA: MDText.com, Inc., 2000.
dc.identifier.citedreferenceRosen PP. Rosen’s breast pathology. Philadelphia, PA: Lippincott Williams & Wilkins, 2008.
dc.identifier.citedreferenceUmlas J. Gynecomastia‐like lesions in the female breast. Arch. Pathol. Lab. Med. 2000; 124; 844 – 847.
dc.identifier.citedreferenceKang Y, Wile M, Schinella R. Gynecomastia‐like changes of the female breast. Arch. Pathol. Lab. Med. 2001; 125; 506 – 509.
dc.identifier.citedreferenceBurgess HE, Shousha S. An immunohistochemical study of the long‐term effects of androgen administration on female‐to‐male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia. J. Pathol. 1992; 170; 37 – 43.
dc.identifier.citedreferenceKlaver M, Dekker MJ, de Mutsert R, Twisk JW, den Heijer M. Cross‐sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta‐analysis. Andrologia 2016; 49; e12660.
dc.identifier.citedreferenceGrilli S, De Giovanni C, Galli MC et al. The simultaneous occurrence of cytoplasmic receptors for various steroid hormones in male breast carcinoma and gynaecomastia. J. Steroid Biochem. 1980; 13; 813 – 820.
dc.identifier.citedreferencePacheco MM, Oshima CF, Lopes MP, Widman A, Franco EL, Brentani MM. Steroid hormone receptors in male breast diseases. Anticancer Res. 1986; 6; 1013 – 1017.
dc.identifier.citedreferenceRosen PP, Menendez‐Botet CJ, Nisselbaum JS, Schwartz MK, Urban JA. Estrogen receptor protein in lesions of the male breast: a preliminary report. Cancer 1976; 37; 1866 – 1868.
dc.identifier.citedreferenceKraus TS, Cohen C, Siddiqui MT. Prostate‐specific antigen and hormone receptor expression in male and female breast carcinoma. Diagn. Pathol. 2010; 5; 63.
dc.identifier.citedreferenceKornegoor R, Vershuur‐Maes AHJ, Buerger H, Van Diest PJ. The 3‐layered ductal epithelium in gynecomastia. Am. J. Surg. Pathol. 2012; 36; 762 – 768.
dc.identifier.citedreferenceWang X, Yarid N, McMahon L, Yang Q, Hicks DG. Expression of androgen receptor and its association with estrogen receptor and androgen receptor downstream proteins in normal/benign breast luminal epithelium. Appl. Immunohistochem. Mol. Morphol. 2014; 22; 498 – 504.
dc.identifier.citedreferenceIshag MT, Bashinsky DY, Beliaeva IV, Niemann TH, Marsh WL Jr. Pathologic findings in reduction mammaplasty specimens. Am. J. Clin. Pathol. 2003; 120; 377 – 380.
dc.identifier.citedreferenceJansen DA, Murphy M, Kind GM, Sands K. Breast cancer in reduction mammoplasty: case reports and a survey of plastic surgeons. Plast. Reconstr. Surg. 1998; 101; 361 – 364.
dc.identifier.citedreferenceAmbaye AB, MacLennan SE, Goodwin AJ, Suppan T, Naud S, Weaver DL. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Plast. Reconstr. Surg. 2009; 124; 1386 – 1392.
dc.identifier.citedreferenceAmerican Psychiatric Association, American Psychiatric Association, DSM‐5 Task Force. Diagnostic and statistical manual of mental disorders: Dsm‐5. 5th edn. Arlington, VA: American Psychiatric Association, 2013; xliv.
dc.identifier.citedreferenceDhejne C, Oberg K, Arver S, Landen M. An analysis of all applications for sex reassignment surgery in Sweden, 1960–2010: Prevalence, incidence, and regrets. Arch. Sex. Behav. 2014; 43; 1535 – 1545.
dc.identifier.citedreferenceGomez‐Gil E, Trilla A, Salamero M, Godas T, Valdes M. Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain. Arch. Sex. Behav. 2009; 38; 378 – 392.
dc.identifier.citedreferenceHoenig J, Kenna JC. The prevalence of transsexualism in England and Wales. Br. J. Psychiatry 1974; 124; 181 – 190.
dc.identifier.citedreferenceLanden M, Walinder J, Lundstrom B. Prevalence, incidence and sex ratio of transsexualism. Acta Psychiatr. Scand. 1996; 93; 221 – 223.
dc.identifier.citedreferenceOlsson SE, Moller AR. On the incidence and sex ratio of transsexualism in Sweden, 1972–2002. Arch. Sex. Behav. 2003; 32; 381 – 386.
dc.identifier.citedreferenceRoss MW, Walinder J, Lundstrom B, Thuwe I. Cross‐cultural approaches to transsexualism. A comparison between Sweden and Australia. Acta Psychiatr. Scand. 1981; 63; 75 – 82.
dc.identifier.citedreferenceSorensen T, Hertoft P. Male and female transsexualism: the Danish experience with 37 patients. Arch. Sex. Behav. 1982; 11; 133 – 155.
dc.identifier.citedreferenceWalinder J. Incidence and sex ratio of transsexualism in Sweden. Br. J. Psychiatry 1971; 119; 195 – 196.
dc.identifier.citedreferenceWeitze C, Osburg S. Transsexualism in Germany: empirical data on epidemiology and application of the German Transsexuals’ Act during its first ten years. Arch. Sex. Behav. 1996; 25; 409 – 425.
dc.identifier.citedreferenceFlores AR, Herman JL, Gates GJ, Brown TNT. How many adults identify as transgender in the United States? The Williams Institute, 2016. https://williamsinstitute.law.ucla.edu/wp-content/uploads/How-Many-Adults-Identify-as-Transgender-in-the-United-States.pdf
dc.identifier.citedreferenceHerman JL, Flores AR, Brown TNT, Wilson BDM, Conron KJ. Age of individuals who identify as transgender in the United States. The Williams Institute, 2017. https://williamsinstitute.law.ucla.edu/wp-content/uploads/TransAgeReport.pdf
dc.identifier.citedreferenceMonstrey S, Hoebeke P, Dhont M et al. Surgical therapy in transsexual patients: a multi‐disciplinary approach. Acta Chir. Belg. 2001; 101; 200 – 209.
dc.identifier.citedreferenceWorld Professional Association for Transgender Health. Standards of care for the health of transsexual, transgender, and gender nonconforming people. Version 7, 2012. https://www.Wpath.Org/site_page.Cfm?Pk_association_webpage_menu=1351&pk_association_webpage=3926
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
his13299.pdf
Size:
663.3KB
Format:
PDF
View/Open
Name:
his13299_am.pdf
Size:
482.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.